Results 81 to 90 of about 29,165 (230)

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, Volume 73, Issue 5, May 2026.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

A rare case of a young man with mediastinal synovial sarcoma

open access: yesRespiratory Medicine Case Reports
Synovial sarcoma is a rare and aggressive tumor that primarily affects soft tissues, including the mediastinum, and predominantly affects younger adults.
Intan Nurani Indrajanu   +2 more
doaj   +1 more source

Synovial Sarcoma of the Esophagus: A Case Report and Review of Literature

open access: yesMiddle East Journal of Digestive Diseases, 2017
Synovial sarcoma is an uncommon soft tissue tumor occurring mainly in the periarticular region of the extremities in young adults. It happens less frequently in the head and neck, mediastinum, lungs, heart, and digestive tract.
Abtin Doroudinia   +4 more
doaj   +1 more source

Synovial Sarcoma of the Anterior Chest Wall: A Case Report

open access: yes대한영상의학회지, 2020
Synovial sarcoma is a malignant soft tissue tumor that usually involves the extremities, particularly near the knees; a synovial sarcoma originating in the chest wall is extremely rare.
Mingook Kim   +2 more
doaj   +1 more source

Soft tissue sarcomas at a glance: clinical, histological, and MR imaging features of malignant extremity soft tissue tumors [PDF]

open access: yes, 2009
Soft tissue sarcomas comprise approximately 1% of malignant tumors. There are more than 50 subtypes, but pleomorphic sarcoma, liposarcoma, leiomyosarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumor account for 75%.
Dijke, C.F. (Cornelis) van   +3 more
core   +3 more sources

Neoadjuvant chemotherapy for soft‐tissue sarcoma of the extremities: A post‐hoc Sarculator‐based risk analysis of the EORTC 62961–ESHO 95 randomized trial

open access: yesCancer, Volume 132, Issue 9, 1 May 2026.
Abstract Background In the EORTC 62961–ESHO 95 randomized trial (European Organization for Research and Treatment 62961–European Society of Hyperthermia Oncology 95; ClinicalTrials.gov identifier NCT00003052), neoadjuvant chemotherapy (NAC) combined with regional hyperthermia (RHT) improved survival in patients with soft tissue sarcoma (tumor size >5 ...
Markus Albertsmeier   +15 more
wiley   +1 more source

Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy

open access: yesCancer Immunology, Immunotherapy
Synovial sarcoma is an aggressive soft-tissue cancer that shows limited responses to current immunotherapeutic approaches using immune checkpoint blockade or adoptive cell therapy.
S. J. Luk   +9 more
doaj   +1 more source

Pediatric Tonsillar Synovial Sarcoma- Very Rare Localization: A Case Report and Review of the Literature

open access: yesTürk Patoloji Dergisi, 2020
Tonsillar synovial sarcoma is an extremely rare entity and only 9 adult patients have been reported up to now. Here, we describe the first pediatric tonsillar synovial sarcoma of the literature in a patient who presented with a 2-month history of ...
Koray YALÇIN   +7 more
doaj   +1 more source

Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome SNP chip [PDF]

open access: yes, 2015
The summary of 336 differentiated data of SNP.
Chun-Xia Liu   +10 more
core   +5 more sources

Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma

open access: yesClinical and Translational Medicine, Volume 16, Issue 5, May 2026.
Retroperitoneal sarcoma cells can secrete prolactin into the bloodstream, inducing hyperprolactinaemia, which subsequently triggers metabolic reprogramming, such as glucose metabolism. SOX4 can function as a transcription factor that facilitates PRL transcription.
Fu'an Xie   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy